Omnicell Stock Performance
| OMCL Stock | USD 43.27 0.59 1.35% |
On a scale of 0 to 100, Omnicell holds a performance score of 15. The company holds a Beta of 1.02, which implies a somewhat significant risk relative to the market. Omnicell returns are very sensitive to returns on the market. As the market goes up or down, Omnicell is expected to follow. Please check Omnicell's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Omnicell's historical price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Omnicell are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Omnicell disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.41) | Five Day Return (0.57) | Year To Date Return (2.44) | Ten Year Return 49 | All Time Return 393.61 |
1 | Hims Hers Health, Inc. Earnings Expected to Grow What to Know Ahead of Next Weeks Release | 10/27/2025 |
2 | Omnicell outlines raised 2025 revenue guidance to 1.177B-1.187B as cloud platform gains traction | 10/30/2025 |
3 | Omnicell, Inc. OMCL Shares Acquired by Connor Clark Lunn Investment Management Ltd. | 11/12/2025 |
4 | Disposition of 2792 shares by Corey Manley of Omnicell at 35.12 subject to Rule 16b-3 | 11/14/2025 |
5 | Omnicell Rethinking Valuation After a Recent Rebound in Share Price | 11/24/2025 |
6 | Analysts Set Omnicell, Inc. Target Price at 42.00 | 11/26/2025 |
7 | What Omnicell s Upward Earnings Estimate Revisions Mean For Shareholders | 11/28/2025 |
8 | Omnicell to Host Innovation Update and QA Session at Upcoming ASHP Midyear Industry Trade Show | 12/01/2025 |
9 | Disposition of 6106 shares by Corey Manley of Omnicell at .9 subject to Rule 16b-3 | 12/03/2025 |
10 | MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System | 12/05/2025 |
11 | PODD Stock Benefits From FDA Approval of Omnipod 5s Enhancements | 12/08/2025 |
12 | Omnicell Earns Relative Strength Rating Upgrade Hits Key Benchmark | 12/09/2025 |
13 | Is it Worth Retaining NEOG Stock in Your Portfolio for Now | 12/10/2025 |
| Begin Period Cash Flow | 501 M | |
| Total Cashflows From Investing Activities | -52.8 M |
Omnicell Relative Risk vs. Return Landscape
If you would invest 3,118 in Omnicell on September 17, 2025 and sell it today you would earn a total of 1,209 from holding Omnicell or generate 38.77% return on investment over 90 days. Omnicell is currently generating 0.5589% in daily expected returns and assumes 2.8139% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Omnicell, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Omnicell Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Omnicell's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Omnicell, and traders can use it to determine the average amount a Omnicell's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1986
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OMCL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Omnicell is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Omnicell by adding it to a well-diversified portfolio.
Omnicell Fundamentals Growth
Omnicell Stock prices reflect investors' perceptions of the future prospects and financial health of Omnicell, and Omnicell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Omnicell Stock performance.
| Return On Equity | 0.0163 | ||||
| Return On Asset | 0.0054 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.98 B | ||||
| Shares Outstanding | 44.88 M | ||||
| Price To Earning | 64.95 X | ||||
| Price To Book | 1.61 X | ||||
| Price To Sales | 1.71 X | ||||
| Revenue | 1.11 B | ||||
| Gross Profit | 516.04 M | ||||
| EBITDA | 90.09 M | ||||
| Net Income | 12.53 M | ||||
| Cash And Equivalents | 244.95 M | ||||
| Cash Per Share | 5.53 X | ||||
| Total Debt | 382.55 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.11 X | ||||
| Book Value Per Share | 27.21 X | ||||
| Cash Flow From Operations | 187.72 M | ||||
| Earnings Per Share | 0.43 X | ||||
| Market Capitalization | 2.01 B | ||||
| Total Asset | 2.12 B | ||||
| Retained Earnings | 382.89 M | ||||
| Working Capital | 219.81 M | ||||
| Current Asset | 50.15 M | ||||
| Current Liabilities | 50.17 M | ||||
About Omnicell Performance
By examining Omnicell's fundamental ratios, stakeholders can obtain critical insights into Omnicell's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Omnicell is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 50.47 | 84.02 | |
| Return On Tangible Assets | 0.01 | 0.02 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Omnicell performance evaluation
Checking the ongoing alerts about Omnicell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Omnicell help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Hims Hers Plunges 29.1 percent in 6 Months Time to Hold the Stock or Sell |
- Analyzing Omnicell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Omnicell's stock is overvalued or undervalued compared to its peers.
- Examining Omnicell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Omnicell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Omnicell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Omnicell's stock. These opinions can provide insight into Omnicell's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in world development indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.36) | Earnings Share 0.43 | Revenue Per Share | Quarterly Revenue Growth 0.1 | Return On Assets |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.